Table 3.
DRR ≥3 months and ≥6 months for each subclassification model
| Low burden (at the time of diagnosis as intermediate-stage HCC) | High burden (group A: at the time of diagnosis as intermediate-stage HCC) | High burden (group B: progressed from low burden) | High burden (group A + B) | |
|---|---|---|---|---|
|
Model 1 (up-to-seven criteria) Child-Pugh A |
||||
| DRR ≥3 months | 46.4% | 39.5% | 28.6% | 38.7% |
| DRR ≥6 months | 26.2% | 15.1% | 7.1% | 14.5% |
| Child-Pugh B | ||||
| DRR ≥3 months | 56.3% | 22.7% | 0.0% | 22.2% |
| DRR ≥6 months | 18.8% | 9.1% | 0.0% | 8.7% |
|
Model 2 (five-seven criteria) Child-Pugh A |
||||
| DRR ≥3 months | 46.5% | 34.7% | 23.1% | 32.3% |
| DRR ≥6 months | 24.5% | 9.9% | 15.4% | 11.0% |
| Child-Pugh B | ||||
| DRR ≥3 months | 37.1% | 24.0% | 0.0% | 23.1% |
| DRR ≥6 months | 14.3% | 8.0% | 0.0% | 6.9% |
|
Model 3 (seven lesions criteria) Child-Pugh A |
||||
| DRR ≥3 months | 45.8% | 34.4% | 21.4% | 31.4% |
| DRR ≥6 months | 23.5% | 10.0% | 14.3% | 11.0% |
| Child-Pugh B | ||||
| DRR ≥3 months | 37.8% | 21.7% | 0.0% | 20.8% |
| DRR ≥6 months | 16.2% | 4.3% | 0.0% | 3.6% |
DRR, durable response rate; HCC, hepatocellular carcinoma.